192 related articles for article (PubMed ID: 9336153)
1. The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma.
Kwong DL; Sham JS; Chua DT; Choy DT; Au GK; Wu PM
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):703-10. PubMed ID: 9336153
[TBL] [Abstract][Full Text] [Related]
2. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
[TBL] [Abstract][Full Text] [Related]
3. Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma.
Li PJ; Jin T; Luo DH; Shen T; Mai DM; Hu WH; Mo HY
PLoS One; 2015; 10(10):e0141332. PubMed ID: 26506559
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity.
Lee AW; Sze WM; Yau TK; Yeung RM; Chappell R; Fowler JF
Radiother Oncol; 2001 Feb; 58(2):121-30. PubMed ID: 11166862
[TBL] [Abstract][Full Text] [Related]
5. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome.
Chua DT; Sham JS; Kwong DL; Tai KS; Wu PM; Lo M; Yung A; Choy D; Leong L
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):711-9. PubMed ID: 9336154
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
[TBL] [Abstract][Full Text] [Related]
7. Investigation of long-term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a retrospective analysis.
Zhao W; Lei H; Zhu X; Li L; Qu S; Liang X
Oncotarget; 2016 Dec; 7(52):86914-86925. PubMed ID: 27894100
[TBL] [Abstract][Full Text] [Related]
8. Tumor volume is not an independent prognostic factor in early-stage nasopharyngeal carcinoma treated by radiotherapy alone.
Chua DT; Sham JS; Leung LH; Tai KS; Au GK
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1437-44. PubMed ID: 15050321
[TBL] [Abstract][Full Text] [Related]
9. The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective Study.
Stoker SD; Fles R; Herdini C; Rijntjes FJ; Tjokronagoro M; Dwidanarti SR; Sikorska K; Leemans CR; Schmidt MK; Al-Mamgani A; Wildeman MA; Haryana SM; Indrasari SR; Tan IB
PLoS One; 2016; 11(3):e0151899. PubMed ID: 27030990
[TBL] [Abstract][Full Text] [Related]
10. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
Hwang JM; Fu KK; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1099-111. PubMed ID: 9719121
[TBL] [Abstract][Full Text] [Related]
11. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; Wong CS; O SK
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1331-8. PubMed ID: 11121630
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy interruption due to holidays adversely affects the survival of patients with nasopharyngeal carcinoma: a joint analysis based on large-scale retrospective data and clinical trials.
Xu C; Yang KB; Feng RJ; Chen L; Du XJ; Mao YP; Li WF; Liu Q; Sun Y; Ma J
Radiat Oncol; 2022 Feb; 17(1):36. PubMed ID: 35183221
[TBL] [Abstract][Full Text] [Related]
13. Early stage nasopharyngeal carcinoma: radiotherapy dose and time factors in tumor control.
Chang JT; See LC; Liao CT; Chen LH; Leung WM; Chen SW; Chen WC
Jpn J Clin Oncol; 1998 Mar; 28(3):207-13. PubMed ID: 9614445
[TBL] [Abstract][Full Text] [Related]
14. Effect of interrupted time during intensity modulated radiation therapy on survival outcomes in patients with nasopharyngeal cancer.
Xu GZ; Li L; Zhu XD
Oncotarget; 2017 Jun; 8(23):37817-37825. PubMed ID: 27911864
[TBL] [Abstract][Full Text] [Related]
15. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
Lu JJ; Shakespeare TP; Thiagarajan A; Zhang X; Liang L; Tan S
Laryngoscope; 2005 May; 115(5):806-10. PubMed ID: 15867644
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma.
Yau TK; Sze WM; Lee WM; Yeung MW; Leung KC; Hung WM; Chan WI
Head Neck; 2004 Dec; 26(12):1024-30. PubMed ID: 15390194
[TBL] [Abstract][Full Text] [Related]
17. The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer.
Chen M; Jiang GL; Fu XL; Wang LJ; Qian H; Chen GY; Zhao S; Liu TF
Lung Cancer; 2000 Apr; 28(1):11-9. PubMed ID: 10704704
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma.
Ozyar E; Yildz F; Akyol FH; Atahan IL
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):101-8. PubMed ID: 11777627
[TBL] [Abstract][Full Text] [Related]
19. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose.
Teo PM; Leung SF; Lee WY; Zee B
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):445-58. PubMed ID: 10661353
[TBL] [Abstract][Full Text] [Related]
20. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
